Levi & Korsinsky Announces Curaleaf Holdings Class Action Investigation; CURLF Lawsuit

Class Action Reports

Levi & Korsinsky Announces Curaleaf Holdings Class Action Investigation; CURLF Lawsuit

Levi & Korsinsky, LLP

September 24, 2019

Levi & Korsinsky, LLP announces that a CURLF class action lawsuit has been commenced on behalf of investors who purchased Curaleaf Holdings, Inc. (CURLF) securities between November 21, 2018 and July 22, 2019. For more on the Curaleaf Holdings Class Action please contact us today.

According to the Curaleaf Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

TO LEARN MORE ABOUT THE CURLF CLASS ACTION, VISIT: https://www.zlk.com/pslra-1/curaleaf-holdings-inc-loss-form?prid=3546&wire=1

If you suffered a loss in Curaleaf Holdings you have until October 4, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com